Lubiao Chen

659 total citations
37 papers, 470 citations indexed

About

Lubiao Chen is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Lubiao Chen has authored 37 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 26 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Lubiao Chen's work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (19 papers). Lubiao Chen is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (19 papers). Lubiao Chen collaborates with scholars based in China, United Kingdom and United States. Lubiao Chen's co-authors include Yuehua Huang, Yurong Gu, Yanlin Huang, Lin Gu, Yifan Lian, Jialiang Wang, Zhiliang Gao, Liang Zhou, Yubao Zheng and Xiaoyan Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Lubiao Chen

36 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lubiao Chen China 12 202 181 167 91 80 37 470
Yihui Rong China 13 168 0.8× 139 0.8× 147 0.9× 81 0.9× 59 0.7× 36 465
Te‐Sheng Chang Taiwan 14 305 1.5× 154 0.9× 278 1.7× 109 1.2× 109 1.4× 50 678
Kazuma Sekiba Japan 14 217 1.1× 307 1.7× 123 0.7× 121 1.3× 139 1.7× 38 598
Tomoaki Iwata Japan 11 179 0.9× 113 0.6× 157 0.9× 101 1.1× 76 0.9× 36 439
Mai Hong Bang Vietnam 11 132 0.7× 136 0.8× 123 0.7× 64 0.7× 78 1.0× 25 377
Yinli Yang China 12 163 0.8× 256 1.4× 93 0.6× 176 1.9× 104 1.3× 17 584
Qingsong Lei China 9 98 0.5× 141 0.8× 88 0.5× 32 0.4× 69 0.9× 12 322
Paul David Germany 11 183 0.9× 101 0.6× 177 1.1× 70 0.8× 33 0.4× 23 440
Shengzheng Luo China 12 132 0.7× 229 1.3× 70 0.4× 114 1.3× 130 1.6× 25 474
Satoshi Tsunematsu Japan 14 190 0.9× 126 0.7× 193 1.2× 71 0.8× 36 0.5× 35 435

Countries citing papers authored by Lubiao Chen

Since Specialization
Citations

This map shows the geographic impact of Lubiao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubiao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubiao Chen more than expected).

Fields of papers citing papers by Lubiao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lubiao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubiao Chen. The network helps show where Lubiao Chen may publish in the future.

Co-authorship network of co-authors of Lubiao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lubiao Chen. A scholar is included among the top collaborators of Lubiao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lubiao Chen. Lubiao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gu, Yurong, Lin Gu, Lubiao Chen, et al.. (2025). Immunotherapy Using HBV Vaccine Pulsed DCs and Induced T‐Cells Combined Antiviral Drugs in Treatment Naive CHB Patients‐A Multi‐Centre Phase II Study. Journal of Viral Hepatitis. 32(2). e14045–e14045. 1 indexed citations
3.
4.
5.
Gu, Yurong, Xiaoyan Li, Lin Gu, et al.. (2020). An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B. Aging. 12(24). 26063–26079. 3 indexed citations
6.
Gu, Yurong, Yifan Lian, Yanlin Huang, et al.. (2020). Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B. BMC Infectious Diseases. 20(1). 509–509. 8 indexed citations
7.
8.
Gu, Yurong, Lubiao Chen, Yifan Lian, et al.. (2019). Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients. Journal of Medical Virology. 92(3). 317–328. 15 indexed citations
9.
Li, Xiaoyan, Liang Zhou, Yurong Gu, et al.. (2019). Quantative HBsAg level correlates dendritic cells maturation in chronic hepatitis B patients. Clinics and Research in Hepatology and Gastroenterology. 44(3). 321–328. 4 indexed citations
10.
Huang, Yanlin, Gang Ning, Lubiao Chen, et al.. (2019). <p>Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma</p>. Cancer Management and Research. Volume 11. 1725–1740. 43 indexed citations
11.
Chen, Lubiao, Yanlin Huang, Liang Zhou, et al.. (2019). Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma. Bioscience Reports. 39(8). 13 indexed citations
12.
Chen, Lubiao, Ying Zhang, Shaoquan Zhang, et al.. (2018). A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion. Archives of Virology. 164(2). 483–495. 4 indexed citations
13.
Chen, Lubiao, Lin Gu, Yurong Gu, et al.. (2018). Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infectious Diseases. 18(1). 295–295. 38 indexed citations
14.
Li, Xiaoyan, Liang Zhou, Lin Gu, et al.. (2017). Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment. Journal of Translational Medicine. 15(1). 220–220. 11 indexed citations
15.
Chen, Lubiao, Lin Gu, Yurong Gu, et al.. (2016). HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression. Scientific Reports. 6(1). 35917–35917. 9 indexed citations
16.
Zhang, Ka, Xingfei Pan, Xin Shu, et al.. (2013). Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis. Cellular Immunology. 282(2). 113–116. 13 indexed citations
17.
Pan, Calvin Q., Yurong Gu, Wei Zhang, et al.. (2012). Dynamic Changes of Lipopolysaccharide Levels in Different Phases of Acute on Chronic Hepatitis B Liver Failure. PLoS ONE. 7(11). e49460–e49460. 27 indexed citations
18.
Zhang, Ka, et al.. (2011). [Comparative study on the clinical characteristics of HBV/HCV co-infection patients with different HCV contaminnation mode].. PubMed. 25(4). 301–3. 2 indexed citations
19.
Zhang, Wei, Youming Chen, Hong Deng, et al.. (2010). Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis. European Journal of Gastroenterology & Hepatology. 22(12). 1–1. 45 indexed citations
20.
Chen, Lubiao, Hong Cao, Yufeng Zhang, et al.. (2010). [Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load].. PubMed. 24(5). 364–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yihui Rong Breakdown of academic impact, for papers by Te‐Sheng Chang Breakdown of academic impact, for papers by Kazuma Sekiba Breakdown of academic impact, for papers by Tomoaki Iwata Breakdown of academic impact, for papers by Mai Hong Bang Breakdown of academic impact, for papers by Yinli Yang Breakdown of academic impact, for papers by Qingsong Lei Breakdown of academic impact, for papers by Paul David Breakdown of academic impact, for papers by Shengzheng Luo Breakdown of academic impact, for papers by Satoshi Tsunematsu
Rankless by CCL
2026